Randing on a scale of 0 to 1with values closer to 1 showing a greater treatment effect the CEI factors in seven different data points: Body weight, waist circumference, HbA1c (blood sugar levels), systolic blood pressure, triglycerides, HDL cholesterol, and LDL cholesterol
Safe Rate: Aim for 1 to 2 pounds per week
MedicalDaily Evidence Check Study type: Phase 3 randomized controlled trial (ATTAIN program) Participants: Adults with obesity or overweight with at least one weight-related comorbidity Approval date: April 1, 2026 What it found: Average weight loss of approximately 12.4% (about 27 lbs) at highest dose over 72 weeks What it did not prove: That it matches injectable GLP-1 efficacy
Subcutaneous Fat vs
Too often, promising technologies become trapped in pilot programmes, fragmented procurement processes or lengthy implementation pathways
They're transdermal patches that pack a punch with vitamins and minerals that absorb into your bloodstream through your skin - how cool is that